ATE509619T1 - Herstellungsverfahren für eine feste dispersion mit itraconazol - Google Patents

Herstellungsverfahren für eine feste dispersion mit itraconazol

Info

Publication number
ATE509619T1
ATE509619T1 AT05765021T AT05765021T ATE509619T1 AT E509619 T1 ATE509619 T1 AT E509619T1 AT 05765021 T AT05765021 T AT 05765021T AT 05765021 T AT05765021 T AT 05765021T AT E509619 T1 ATE509619 T1 AT E509619T1
Authority
AT
Austria
Prior art keywords
itraconazole
solid dispersion
present
containing solid
preparing
Prior art date
Application number
AT05765021T
Other languages
English (en)
Inventor
Hong-Ryeol Jeon
Se-Geun Yu
Bong-Sang Lee
Se-Heum Oh
Jeong-Seo Park
Dong-Ryun Oh
Do-Woo Kwon
Original Assignee
Ctc Bio Inc
Hong-Ryeol Jeon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctc Bio Inc, Hong-Ryeol Jeon filed Critical Ctc Bio Inc
Application granted granted Critical
Publication of ATE509619T1 publication Critical patent/ATE509619T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT05765021T 2004-06-24 2005-06-24 Herstellungsverfahren für eine feste dispersion mit itraconazol ATE509619T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040047369 2004-06-24
PCT/KR2005/001991 WO2006001669A1 (en) 2004-06-24 2005-06-24 Manufacturing method of solid dispersion containing itraconazole

Publications (1)

Publication Number Publication Date
ATE509619T1 true ATE509619T1 (de) 2011-06-15

Family

ID=35782042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05765021T ATE509619T1 (de) 2004-06-24 2005-06-24 Herstellungsverfahren für eine feste dispersion mit itraconazol

Country Status (6)

Country Link
US (1) US9492446B2 (de)
EP (1) EP1765350B1 (de)
KR (1) KR100663079B1 (de)
CN (1) CN1997372B (de)
AT (1) ATE509619T1 (de)
WO (1) WO2006001669A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007308480A (ja) * 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 腸溶性固体分散体を含んでなる固形製剤
US10004682B2 (en) 2010-08-24 2018-06-26 Rutgers, The State University Of New Jersey Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
WO2012039768A2 (en) * 2010-09-24 2012-03-29 Texas Southern University Itraconazole formulations
EP4076501A4 (de) 2019-12-16 2024-05-08 Rutgers, the State University of New Jersey Kontinuierliche verfahren zur herstellung von imprägnierten porösen trägern und zur herstellung von arzneimitteln mit imprägnierten porösen trägern

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
US5883097A (en) * 1998-04-16 1999-03-16 Schering Corporation Soluble azole antifungal salt
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
CA2291346A1 (en) * 1999-11-26 2001-05-26 Bernard Charles Sherman Antifungal solutions
KR100394075B1 (ko) * 2000-04-22 2003-08-06 한국화학연구원 생체이용율이 증진된 경구용 이트라코나졸 제제
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
EP1499289B1 (de) * 2002-03-29 2008-07-23 Alza Corporation Volumensparende arzneiform zur kontrollierten freisetzung
WO2004004683A1 (en) * 2002-07-04 2004-01-15 Janssen Pharmaceutica N.V. Solid dispersions comprising two different polymer matrixes

Also Published As

Publication number Publication date
US9492446B2 (en) 2016-11-15
CN1997372B (zh) 2010-06-02
KR20060046529A (ko) 2006-05-17
EP1765350B1 (de) 2011-05-18
EP1765350A1 (de) 2007-03-28
US20090298847A1 (en) 2009-12-03
KR100663079B1 (ko) 2007-01-02
CN1997372A (zh) 2007-07-11
EP1765350A4 (de) 2009-09-09
WO2006001669A1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
MY148096A (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
MY148483A (en) 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
MY148258A (en) Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
PL381801A1 (pl) Pochodne mocznika, kompozycje zawierające pochodne mocznika oraz zastosowanie pochodnych mocznika do wytwarzania leku do leczenia skurczowej niewydolności serca
EA201070700A1 (ru) Способы получения циклоалкилкарбоксамидопиридинбензойных кислот
MX2010009654A (es) Derivados de acido carboxilico de conformacion restringida utiles para tratar trastornos metabolicos.
EA201001444A1 (ru) Синтез эфиров или тиоэфиров адипата
MX2010006179A (es) Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico.
MX2007006311A (es) Acidos hidroxibifenilcarboxilicos y derivados, metodo para producirlos y su uso.
ATE457310T1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MY148297A (en) Process for modifying drug crystal formation
MY150219A (en) Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
UA111506C2 (uk) Розчин для орального введення
UA91332C2 (uk) Кристалічна малеатна сіль хіназоліну (варіанти), корисна як антиангіогенний агент
ATE509619T1 (de) Herstellungsverfahren für eine feste dispersion mit itraconazol
ATE386734T1 (de) Verfahren zur herstellung von (4-hydroxy-6-oxo- tetrahydropyran-2-yl) acetonitril und dessen derivaten
IL176915A0 (en) Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
DK1745010T3 (da) Substituerede cyklohexyl-1,4-diaminderivater
CY1112979T1 (el) Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου
MXPA05008990A (es) Derivados de acido alcanoico sustituido con cicloalquilo, metodos para su produccion y su uso como medicamentos.
TW200719889A (en) Amino acid derivatives
TW200740798A (en) Substituted amides, process for their manufacture and use thereof as medicaments
BRPI0513881A (pt) processo para a preparação de compostos opticamente ativos
NO20033706D0 (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties